Respiratoriorum pathogens combined
Product Name
HWTS, Rt158a Respiratoriorum pathogens combined deprehensio Kit (Fluorescence PCR)
Certificatorium
CE
Epidemiology
Corona Virus Morbus MMXIX, referred to as`COVID 19`, Refert ad Pneumonia fecit per MMXIX, NCOV infectio. MMXIX, NCOV est coronavirus ad β genus. Covi-XIX est acutus respiratorii infectious morbo, et populatio est plerumque susceptibilis. In praesens, quod fons infectio est maxime aegros infici ab MMXIX, NCOV, et asymptomatic infectae personas potest etiam facti sunt fons infectio. Ex in hodiernae epidemiological inquisitionis, in incubitu tempus est 1-14 dies, plerumque 3-7 diebus. Febrem, sicca tussis et lassitudine sunt principalis manifestationes. A paucis aegris habebat symptoms ut nasi obstructio, liquescit naribus, faucium, myalgia et fluxus etc.
Influenza, vulgo quod "morbum", est acuti respiratorii infectious morbus per influenza virus. Est altus infectious. Est maxime traducitur a tussis et sternumentum. Solet erumpit in fonte et hiems. Influenza viruses are divided into influenza A (IFV A), influenza B (IFV B), and Influenza C (IFV C) three types, all belong to sticky virus, cause human disease mainly for influenza A and B viruses, it is a single -Stranded, segmed RNA virus. Influenza virus est acutus respiratorii infectio, inter H1N1, H3N2 et alia subtypes, quae sunt proni ad mutationem et tumultu terrarum. "Shift" refertur ad mutationem de influenza virum, unde in cessum a virus "subtype." Influenza b virus dividitur in duas linagages, Yamagata et Victoria. Influenza b virus solum habet antigenic egisse, et evades humana immune ratio in custodia et eliminanda per mutationem. Sed evolutione celeritas influenza B virus est tardius quam humana influenza virus. Influenza B virus potest etiam humana respiratoriorum infectiones et plumbum ad epidemics.
Respiratoriorum Synytic Virum (VUL) est RNA virus, quae ad Paramyxoviridae Family. Est traducitur a aere droplets et propinquus contactus et est principalis morbificas inferioris respiratorii tractu infectio infantes. Infantes infectam cum RSV ut develop gravibus bronchiolitis et Pneumonia, quae ad asthma in filios. Infantes sunt gravibus symptoms, quos possidet princeps febris, rhinitis, pharyngitis et laryngitis et bronchiolitis et pneumonia. Pauci infantes potest esse complicated cum Otitis media, Pleurisy et myocarditis, etc. superioris respiratorii tractu infectio est principalis indicium infectio in adultis et senior liberos.
Channel
| Fam | SARS-CoV-2 |
| Vic (Hex) | VULGATE |
| CYV | Ifv est |
| ROX | Ifv b |
| Quasar DCCV | Internum |
Technical parametri
| Repono | -18 ℃ |
| PLUTEUM-vitae | XII mensibus |
| Specimen Type | Oropharyngeal Swab |
| Ct | ≤38 |
| LOD | MMXIX, NCOV: 300Copies / ml Influenza virus / Influenza B virus / respiratorii Synytic virus: 500copies / ml |
| Specifica | a) Cross-Reactivity results ostendere quod non est crucem reactionem inter ornamentum et humana coronavirus Sarsr-Cov, Mersr-Cov, HCOV, HCV, HCOV-229E, HCOV-HCU1, HCOV-NL63, parainfluenza virus I, II, III, Rhinovirus A, B, C, Chlamydia Pneumoniae, Humanum Metapneumovirus, Enterovirus A, B, C, D, Eriph, Barr Virus, Measles Virus, Humanum Cytomegalo virus, Rotavirus, Norouenzae, Staphylococcus, Streptococcus Pneumoniae, Streptococcus Pyogenes, Klebsiella Pneumoniae, Mycobacterium tuberculosis, Fumus Aspergillus, Candida Albicans, Candida Glabrata, Pneumocystis Jiroveci et Natum et Humanum GenomiC b) Anti-intercessiones facultatem: Select mucin (60mg / ml), X% (v / v) et sanguinem et phenylephrine (2mg / ml), sodium (2mg / ml), sodium (2mg / ml), sodium (2mg / ml), sodium (2mg / ml), sodium (2mg / ml), sodium (2mg / ml), sodium (2mg / ml) (20mg / comprehendo conservativa) (20mg / comprehendo conservativa) (20mg / comprehendo conservatives) (20mg /) (20mg) (20mg), (20mg),) , Beclomethasone (20mg / ml), dexamethasone (20mg / ml): flunisolide (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), alpha interferon (800IU/mL ) Zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), peramivir (1mg/mL), lopinavir(500mg/mL), ritonavir(60mg/mL), mupirocin (20mg/mL), azithromycin ( 1mg / ml), Ceftriaxone (40μg / ml), Meropenem (200mg / ml), levoflowacin (10μg / ml) et tobramycin (0.6mg / ml ad interpositum, et eventus non intercessiones in test results de pathogens. |
| COMPRESSUS | BIOD CFX96 Real-vicis PCR ratio Rotor-gene Q 5plexa HRM Platform Real-vicis PCR ratio |
